Italfarmaco To Seek Givinostat Approvals After Phase III Success In DMD

Capricor Reported Long-Term Data For Its Cell Therapy

Young male physiotherapist helping patient with lifting dumbbells exercises in office
Italfarmaco's givinostat succeeded across all muscle function measures • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D